Mitigating lung damage, mortality due to SARS-CoV-2
University of Illinois ChicagoResearchers report that a drug approved for treating patients with autoimmune disease helped to prevent lung damage and death in mice infected with the SARS-CoV-2 virus, which causes COVID-19 in humans.